Cantourage Group SE
ISIN: DE000A3DSV01 | Ticker: HIGH | LEI: 3912003NCTLO6YHA9V48
Country: Germany
Cantourage is a publicly listed, leading European medical cannabis company. The Berlin-based company with subsidiaries in the United Kingdom and Poland, was founded in 2019 by industry pioneers Norman Ruchholtz, Dr. Florian Holzapfel and Patrick Hoffmann. Cantourage enables producers from all over the world to become part of the rapidly growing European medical cannabis market in a faster and more cost-effective way, while guaranteeing and developing the highest European quality standards. The company offers products in all relevant market segments: dried flowers, extracts, Dronabinol and pharma-grade Cannabidiol. The company was listed on the Frankfurt Stock Exchange on 11 November 2022 and is listed under the stock ticker “HIGH”.
Year founded2019
Served areaEurope
HeadquartersFeurigstraße 54, 10827 Berlin – Germany
| Date | Trading entity / Person | Association | Trade type | Volume |
|---|---|---|---|---|
| 07.09.23 | CDXX Vermögens- und Verwaltungs GmbH | Close relation | Sell | EUR 105,490.00 |
| 17.08.23 | HOFY4 GmbH | Close relation | Sell | EUR 40,023.24 |
| 17.08.23 | HOFY4 GmbH | Close relation | Sell | EUR 14,257.90 |
| 20.06.23 | HOFY4 GmbH | Close relation | Sell | EUR 80,519.46 |
| 14.06.23 | HOFY4 GmbH | Close relation | Sell | EUR 1,658.50 |
DE000A3DSV01
LEI3912003NCTLO6YHA9V48
SectorKeep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.